 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aligos Therapeutics
ALGS
|
30.2 |
$ 8.53 |
-2.18 % |
$ 84.3 M |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
131 |
$ 3.73 |
1.78 % |
$ 8.97 B |
Australia |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
6.61 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
BioNTech SE
BNTX
|
35.7 |
$ 98.87 |
2.24 % |
$ 27.2 B |
Germany |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Burford Capital Limited
BUR
|
6.35 |
$ 4.68 |
4.23 % |
$ 760 M |
Britain |
 |
Cabaletta Bio
CABA
|
50.3 M |
$ 3.26 |
1.72 % |
$ 328 M |
USA |
 |
Applied Therapeutics
APLT
|
54.1 |
- |
- |
$ 8.42 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
2.27 |
- |
- |
$ 546 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
1.73 |
$ 21.44 |
0.37 % |
$ 1 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
3.91 K |
- |
- |
$ 169 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Clearside Biomedical
CLSD
|
12.3 |
- |
- |
$ 25.3 M |
USA |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
1.42 |
$ 1.53 |
4.08 % |
$ 393 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 |
$ 3.01 |
3.08 % |
$ 4.96 M |
Israel |
 |
Aquestive Therapeutics
AQST
|
10.5 |
$ 4.14 |
-1.31 % |
$ 443 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
9.15 |
$ 25.31 |
4.93 % |
$ 3.22 B |
USA |
 |
Chimerix
CMRX
|
320 |
- |
- |
$ 756 M |
USA |
 |
Concert Pharmaceuticals
CNCE
|
41.3 |
- |
- |
$ 401 M |
USA |
 |
AIkido Pharma
AIKI
|
0.935 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Celldex Therapeutics
CLDX
|
1.32 K |
$ 33.28 |
2.1 % |
$ 2.21 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
4.27 |
$ 1.49 |
1.02 % |
$ 397 M |
Britain |
 |
Cidara Therapeutics
CDTX
|
116 |
- |
- |
$ 1.41 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
2.17 |
- |
- |
$ 96.9 B |
Britain |
 |
CTI BioPharma Corp.
CTIC
|
10.2 |
- |
- |
$ 1.2 B |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |